• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Authors » Lynn Yoffee

Articles by Lynn Yoffee

New test IDs patients at risk of developing kidney injury

April 1, 2010
By Lynn Yoffee

Flexible silicon tech may yield new wave of implanted devices

March 29, 2010
By Lynn Yoffee
The electrical interface in standard implantable medical devices hasn't changed much in decades. There's an electrode contact, a wire soldered to that and it goes back to a can that contains a battery and the active electronics. Researchers at the University of Pennsylvania (Philadelphia) have developed a flexible silicon technology half the diameter of a human hair that brings electronic circuits directly to the tissue rather than having them located remotely that, if validated, could herald a new generation of implantable medical devices.(Medical Device Daily)
Read More

AGA Medical gets IDE for cardiac plug designedto prevent stroke

March 26, 2010
By Lynn Yoffee

pCLE is almost ready for prime time cancer testing

March 25, 2010
By Lynn Yoffee

OrSense wins its first FDA approval for oximetry sensor

March 24, 2010
By Lynn Yoffee

FDA clears 1st fully implanted hearing restoration device

March 19, 2010
By Lynn Yoffee
The FDA has approved a new kind of hearing device made by Envoy Medical (Minneapolis) that the agency said represents a breakthrough technology to restore hearing. (Medical Device Daily)
Read More

CareFusion launches combined kyphoplasty, vertebroplasty kit

March 18, 2010
By Lynn Yoffee

Boston Scientific releases few details on defibrillator recall

March 17, 2010
By Lynn Yoffee
"Boston Scientific needs a defibrillator" (SeekingAlpha.com). "The Toyota of the medical industry" (Wall Street Journal blog). "Boston Scientific cut to sell by Goldman Sachs" (MarketWatch.com). "Analysts bemoan lack of information" (WSJ blog). (Medical Device Daily)
Read More

Boston Sci halts defibrillator shipments, recalls inventory

March 16, 2010
By Lynn Yoffee
In what may be hailed by some as one of the biggest medical device recalls ever, Boston Scientific (Natick, Massachusetts) on Monday stopped shipment and is retrieving field inventory of all its implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds). The move caused a spike in trading and the company's stock dove 16.45% at midday. (Medical Device Daily)
Read More

MicroPhage on cusp of delivering 1st of its bacteriophage tests in U.S.

March 15, 2010
By Lynn Yoffee
Being hospitalized for anything is traumatic to most people; the insult and threat on top of that is the hospital-acquired deadly infection known as methicillin-resistant Staphylococcus aureus (MRSA). Current diagnostic techniques take days. Newcomer MicroPhage (Longmont, Colorado) has just submitted human data from a pivotal clinical study of its MRSA/MSSA (methicillin-sensitive Staphylococcus aureus) Blood Culture Test to support FDA 510(k) clearance of the test that produces results onsite in five hours. (Medical Device Daily)
Read More
Previous 1 2 3 4 5 6 7 8 9 10 11 … 50 51 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 9, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for May 9, 2025.
  • US flag, stock market chart, White House

    100 days of uncertainty

    BioWorld
    The first 100 days of the Trump administration have been nothing short of chaotic, both in the U.S. and throughout the world. Shining a light through the...
  • AI generated, 3D rendering of protein degradation

    AACR 2025: Induced proximity strategy, beyond degraders

    BioWorld
    Targeted protein degradation has yet to notch its first approval. But with more than two dozen agents now in clinical trials, the strategy’s ultimate clinical...
  • NME Digest: Q1 2025

    BioWorld
    A quarterly dynamic table featuring new molecular entities (NMEs) revealed for the first time in current literature, at congresses and in company communications...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe